Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

2020462 citationsJournal Articlebronze Open Access

Authors

Céline Louapre · Sorbonne Université

Nicolas Collongues · Hôpitaux Universitaires de Strasbourg

Bruno Stankoff · Sorbonne Université

C. Giannesini · Assistance Publique – Hôpitaux de Paris

Caroline Papeix · Sorbonne Université

Caroline Bensa · Fondation Ophtalmologique Adolphe de Rothschild

Romain Deschamps

Abstract

In this registry-based cohort study of patients with MS, age, EDSS, and obesity were independent risk factors for severe COVID-19; there was no association found between DMTs exposure and COVID-19 severity. The identification of these risk factors should provide the rationale for an individual strategy regarding clinical management of patients with MS during the COVID-19 pandemic.

Topics & Keywords

Multiple Sclerosis Research Studies SARS-CoV-2 and COVID-19 Research Polyomavirus and related diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Neurology

Volume 77, Issue 9, pp. 1079-1079

DOI: 10.1001/jamaneurol.2020.2581

Field-Weighted Citation Impact: 59.82